Motor Neurone Disease Trial, Recruiting (NCT05095571)

Motor Neurone Disease Trial, Recruiting NCT05095571 Sponsor: Haukeland University Hospital Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05095571 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must have already taken part in the original NO-ALS study and completed it (patients from either treatment group in that study are welcome to apply)

Who may not be able to join:

People who have dementia, frontotemporal dementia (a type of brain condition affecting behaviour and thinking), or another brain or nerve condition that would make it hard to follow the study rules
People who have a serious metabolic condition (such as a problem with how the body processes energy), cancer, or another condition — physical or mental — that would make participation very difficult
People who have had a tracheostomy (a surgical procedure where a breathing tube is placed directly into the throat) as part of their ALS treatment
People whose doctor involved in the trial believes they may not survive long enough to be able to follow the study procedures
People who are taking Vitamin B3 or blueberry extract supplements outside of this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ole-Bjørn Tysnes, Haukeland University Hospital

Phone: +4755975063

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05095571

Sponsor: Haukeland University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: +4755975063

More information: https://clinicaltrials.gov/study/NCT05095571

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must have already taken part in the original NO-ALS study and completed it (patients from either treatment group in that study are welcome to apply)

Who may not be able to join:

People who have dementia, frontotemporal dementia (a type of brain condition affecting behaviour and thinking), or another brain or nerve condition that would make it hard to follow the study rules
People who have a serious metabolic condition (such as a problem with how the body processes energy), cancer, or another condition — physical or mental — that would make participation very difficult
People who have had a tracheostomy (a surgical procedure where a breathing tube is placed directly into the throat) as part of their ALS treatment
People whose doctor involved in the trial believes they may not survive long enough to be able to follow the study procedures
People who are taking Vitamin B3 or blueberry extract supplements outside of this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Haukeland University Hospital

Registry

ClinicalTrials.gov

Start date

7 October 2021

Est. completion

31 December 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Incidence of adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov